Skip to main content
EMRELIS 100 mg/mL injection, powder, lyophilized, for solution by AbbVie Inc.
EMRELIS, 100 mg/mL, injection, powder, lyophilized, for solution Available on prescription only. Listed by AbbVie Inc..
Prescription only

EMRELIS

Telisotuzumab Vedotin

Listed by AbbVie Inc.

Strength
100 mg/mL
Form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous

What it contains

  • Telisotuzumab Vedotin 100 mg/mL

FDA record

Dosage form Injection, Powder, Lyophilized, For Solution
Route Intravenous
Approval route BLA — biologic licence
NDC code 0074-1055
FDA application BLA761384
RxNorm concept 2714245
Package sizes listed 1
Marketed since May 2025

Other products containing Telisotuzumab Vedotin

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

EMRELIS

Telisotuzumab Vedotin

Strength
20 mg/mL
Form
Injection, Powder, Lyophilized, For Solution
Rx only

AbbVie Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.